Key Takeaways
- • STARTEEPO SICAV, a Prague-based hedge fund, has built a 7.34% beneficial ownership stake in Xerox Holdings (9.64 million shares including call options) for approximately $23.15 million and issued a September 7 activist letter urging a formal strategic review of Xerox Financial Services (XFS).
- • The fund values XFS at roughly $7.69 per share on a standalone basis—more than double Xerox's then-current full company share price—arguing the captive finance unit is significantly undervalued within the conglomerate structure.
- • STARTEEPO is calling for a Board-led strategic review with independent advisers to evaluate monetization options for XFS, including joint venture, capital partnership, partial sale, or full divestiture, to be completed ahead of 2028 debt maturities.
- • The activist fund is demanding enhanced disclosure on XFS receivables, funding costs, credit spreads, credit performance metrics, and return on equity, citing insufficient transparency on the finance subsidiary's operations and profitability.
- • STARTEEPO maintains support for Xerox's operational turnaround and Lexmark integration strategy while targeting value recognition in the captive finance business as a distinct catalyst.
Summary
STARTEEPO SICAV, a Prague-based alternative investment fund, escalated its public position on Xerox Holdings on September 7, 2026, with a formal activist letter and amended Schedule 13D filing disclosing a 7.34% beneficial ownership stake built through direct equity and call option positions. The fund, controlled by František Bostl, holds 8 million shares directly (6.09% of outstanding) plus additional call options, representing a total beneficial position of 9.64 million shares acquired at an aggregate cost of approximately $23.15 million. This stake places STARTEEPO among Xerox's meaningful public shareholders and provides a formal platform for activist engagement.
The core of STARTEEPO's campaign centers on Xerox Financial Services, the company's captive finance subsidiary, which the fund argues is trading at a significant valuation discount within the larger conglomerate. Using its own financial methodology, STARTEEPO estimates XFS could be valued at $7.69 per share on a standalone basis—representing more than double Xerox's full-company share price at the time of the letter. This valuation gap forms the crux of the fund's argument that XFS represents embedded, unrecognized shareholder value that should be unlocked through a formal strategic review.
STARTEEPO's activist campaign focuses on two complementary demands: enhanced disclosure and a structured strategic alternatives process. The fund is calling for clearer Board-level transparency regarding XFS operations, specifically requesting detailed disclosures on receivables quality, funding cost structure, credit spreads, credit performance trends, and return on equity metrics. Concurrently, STARTEEPO urges Xerox's Board to commission an independent advisor-led strategic review to evaluate multiple monetization pathways, including joint venture arrangements, minority capital partnerships, partial asset sales, or full divestiture of XFS. The fund emphasizes that any such review should conclude well ahead of 2028 debt maturities, establishing a clear timeline for Board action.
Notably, STARTEEPO frames its activism as complementary to—rather than contradictory to—Xerox's current strategic priorities, affirming its support for the company's operational turnaround initiatives and integration with Lexmark. The fund's objective is value realization within the captive finance segment, positioning the XFS strategic review as a distinct, time-bound opportunity to improve overall shareholder value. The 13D filing and accompanying letter represent a standard activist public-equity play targeting captive finance value recognition, with no announced sale process or banker mandate yet materialized.
The core of STARTEEPO's campaign centers on Xerox Financial Services, the company's captive finance subsidiary, which the fund argues is trading at a significant valuation discount within the larger conglomerate. Using its own financial methodology, STARTEEPO estimates XFS could be valued at $7.69 per share on a standalone basis—representing more than double Xerox's full-company share price at the time of the letter. This valuation gap forms the crux of the fund's argument that XFS represents embedded, unrecognized shareholder value that should be unlocked through a formal strategic review.
STARTEEPO's activist campaign focuses on two complementary demands: enhanced disclosure and a structured strategic alternatives process. The fund is calling for clearer Board-level transparency regarding XFS operations, specifically requesting detailed disclosures on receivables quality, funding cost structure, credit spreads, credit performance trends, and return on equity metrics. Concurrently, STARTEEPO urges Xerox's Board to commission an independent advisor-led strategic review to evaluate multiple monetization pathways, including joint venture arrangements, minority capital partnerships, partial asset sales, or full divestiture of XFS. The fund emphasizes that any such review should conclude well ahead of 2028 debt maturities, establishing a clear timeline for Board action.
Notably, STARTEEPO frames its activism as complementary to—rather than contradictory to—Xerox's current strategic priorities, affirming its support for the company's operational turnaround initiatives and integration with Lexmark. The fund's objective is value realization within the captive finance segment, positioning the XFS strategic review as a distinct, time-bound opportunity to improve overall shareholder value. The 13D filing and accompanying letter represent a standard activist public-equity play targeting captive finance value recognition, with no announced sale process or banker mandate yet materialized.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.